50 Pharmacotherapy Studies Every Palliative Practitioner Should Know
Series: Fifty Studies Every Doctor Should Know;
- Publisher's listprice GBP 38.99
-
18 627 Ft (17 740 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 10% (cc. 1 863 Ft off)
- Discounted price 16 764 Ft (15 966 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
18 627 Ft
Availability
Estimated delivery time: In stock at the publisher, but not at Prospero's office. Delivery time approx. 3-5 weeks.
Not in stock at Prospero.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher OUP USA
- Date of Publication 22 April 2025
- ISBN 9780197770337
- Binding Paperback
- No. of pages352 pages
- Size 235x156x18 mm
- Weight 526 g
- Language English
- Illustrations 48 B&W illustrations 656
Categories
Short description:
50 Phamarcotherapy Studies Every Palliative Practitioner Should Know is a compilation of key pharmacotherapy studies that form the foundation of evidence-based practice. For each study, a concise summary is presented with an emphasis on the results and limitations of the study, and its implications for practice. Brief information on other relevant studies is provided, and an illustrative clinical case offers readers the opportunity to conceptualize findings. This book is a must-read for palliative practitioners, pharmacists, advance practice nurses, physician assistants, and anyone who wants to learn more about the data behind clinical practice.
MoreLong description:
50 Phamarcotherapy Studies Every Palliative Practitioner Should Know is a compilation of key pharmacotherapy studies that form the foundation of evidence-based practice. The studies cover topics including: agitation and delirium, fatigue, nausea and vomiting, pain, anorexia and cachexia, ALS, seizure, dyspnea, anxiety, pruritis, symptom clusters, COPD, cancer, and more. For each study, a concise summary is presented with an emphasis on the results and limitations of the study, and its implications for practice. Brief information on other relevant studies is provided, and an illustrative clinical case offers readers the opportunity to conceptualize findings. As with all books in the "50 Studies" series, each study was selected using an objective selection criterion that included citations per year, high levels of evidence, clinical studies and trials, and a 3-stage Delphi review by international experts in the field. This book is a must-read for palliative practitioners, pharmacists, advance practice nurses, and physician assistants, and anyone who wants to learn more about the data behind clinical practice.
MoreTable of Contents:
Contributors
1 Low-Dose Neuroleptics for Treating Delirium
2 Dexamethasone in Addition to Metoclopramide for Chronic Nausea in Patients With Advanced Cancer
3 Ibandronate Compared to Radiotherapy for Metastatic Bone Pain in Patients With Solid Tumors
4 Duloxetine for Cancer-Related Neuropathic Pain
5 Methadone as a Coanalgesic
6 Methadone Versus Fentanyl for Nociceptive Cancer Pain
7 Improving Metastatic Bone Pain With Opioid Adjuvants: Low-Dose Antidepressants and Low-Dose Pregabalin
8 Intranasal Midazolam Versus Rectal Diazepam for the Home Treatment of Acute Seizures
9 Isopropyl Alcohol Nasal Inhalation for Nausea in the Emergency Department: A Randomized Controlled Trial
10 Methylphenidate for Cancer-Related Fatigue
11 Duloxetine for the Treatment of Chemotherapy-Induced Peripheral Neuropathy
12 Efficacy of Oral Risperidone, Haloperidol, or Placebo for Symptoms of Delirium Among Patients in Palliative Care: A Randomized Clinical Trial
13 The Use of Very Low-Dose Methadone for Palliative Pain Control
14 Opioid Therapy for Dyspnea Associated With Chronic Obstructive Lung Disease: Benefits and Harms
15 Effect of Prophylactic Subcutaneous Scopolamine Butylbromide on Death Rattle in Patients at the End of Life
16 Palmitoylethanolamide (PEA) as Adjunctive Therapy May Offer Benefit to Patients With Major Depressive Disorder (MDD)
17 Haloperidol as an Adjunct Therapy for Pain and Nausea in Acute Gastroparesis
18 Neuroleptic Strategies for Terminal Agitation in Patients With Cancer and Delirium at an Acute Palliative Care Unit: A Single-Center, Double-Blind, Parallel-Group, Randomized Trial
19 Methadone Versus Morphine as a First-Line Strong Opioid for Cancer Pain
20 Methylnaltrexone for Opioid-Induced Constipation
21 Lorazepam and Haloperidol Versus Haloperidol Monotherapy for the Treatment of Agitated Delirium
22 Treatment of Cancer-Related Fatigue With Dexamethasone
23 Octreotide in Malignant Bowel Obstruction
24 Efficacy of Levetiracetam, Fosphenytoin, and Valproate for Established Status Epilepticus by Age Group (ESETT): A Double-Blind, Responsive-Adaptive, Randomized Controlled Trial
25 Donepezil and Memantine for Moderate-to-Severe Alzheimer Disease: When Is It Appropriate to Discontinue Therapy?
26 Use of Mirtazapine for Cancer-Associated Anorexia and Cachexia
27 Epidemiology of Amyotrophic Lateral Sclerosis and Effect of Riluzole on Disease Course
28 Topical Lorazepam, Diphenhydramine, and Haloperidol for Nausea in Cancer Patients
29 Gabapentin for Uremic Itching
30 Treatment of Malodorous Tumors With Topical Metronidazole
31 The Effect of Cannabis on Appetite and Quality of Life in Patients With Cancer-Related Anorexia-Cachexia Syndrome
32 Olanzapine for the Treatment of Advanced Cancer- Related Chronic ausea and/ or Vomiting
33 Safety and Benefit of Discontinuing Statin Therapy in Advanced Life-Limiting Illness
34 Corticosteroids for Cancer-Related Pain, Fatigue, and Anorexia
35 Role of Paracetamol (Acetaminophen) for Cancer Pain Requiring High-Dose Opioids
36 Treatment of Painful Wounds With Topical Morphine
37 Dexamethasone in the Prophylaxis of Radiation-Induced Pain Flare After alliative Radiotherapy for Bone Metastases
38 Psilocybin for Depression and Anxiety in Cancer Patients
39 The Use of Opioids for Breakthrough Pain in Acute Palliative Care Unit by sing Doses Proportional to Opioid Basal Regimen
40 Perioperative Pregabalin for Prevention of Postmastectomy Pain yndrome
41 Morphine for Chronic Breathlessness
42 Hyoscine Butylbromide for the Management of Death Rattle
43 Randomized Controlled Trial of Oral Docusate in Patients on Hospice
44 Equianalgesic Conversion From Intravenous Hydromorphone to Oral Opiods
45 Guideline-Driven Versus Single-Agent Antiemetic Therapy in Patients With dvanced Cancer
46 Safety of Morphine Delivered via Patient-Controlled Analgesia Devices in the Pediatric Population
47 Efficacy and Safety of Valproic Acid Versus Haloperidol in Patients With
Acute Agitation: Results of a Randomized, Double-Blind, Parallel-Group Trial
Somayeh Yunesian, Alireza Azadbakht, and Ladan Mirmohseni
48 Ketamine: A Toxic Adjunct in Pain Management for Cancer?
49 American (Wisconsin) Ginseng for Cancer-Related Fatigue
50 Management of Intractable Hiccups
Index
Wolverine Noir
5 272 HUF
4 850 HUF
